U.S. Pharma Stock News

Riverwater Partners' Q1 2026 letter identifies Haemonetics (NYSE:HAE) as a top performance detractor for the quarter. The firm highlights renewed market share gains in plasma collection and improved confidence in Haemonetics' business fundamentals. The commentary follows a period of challenges in interventional cardiology and focuses on execution and market share trends. Haemonetics, trading at about $59.93, has had a difficult stretch, with the share price down 25.1% year to date and 28.4%...

Recent analyst forecasts around American Tower (AMT) earnings, pointing to lower EPS alongside higher revenue and shifting segment trends, have put the stock in focus for investors who are watching how its business mix is evolving. See our latest analysis for American Tower. At a share price of US$178.21, American Tower’s recent 6.54% 1 month share price return contrasts with a 12.35% 1 year total shareholder return decline. This suggests fading longer term momentum even as short term...

Investors may be wondering if AGNC Investment at around US$11.02 is still offering value, or if most of the easy gains are already on the table. The stock has recent returns of 1.1% over 7 days, 8.7% over 30 days, 0.8% year to date, 43.9% over 1 year, 71.5% over 3 years and 19.8% over 5 years. This provides plenty of data points to weigh potential reward against risk. Recent headlines around AGNC Investment have focused on its position in the mortgage REIT space and ongoing interest in...

Check Point Software Technologies (NasdaqGS:CHKP) has partnered with Google Cloud to secure AI agent environments, focusing on governance, visibility, and real time protection. The company recently received Frost & Sullivan's Technology Innovation Leadership award for its approach to web application and API protection. These developments highlight Check Point's push into AI driven and cloud native security solutions beyond its traditional firewall and network security offerings. For you as...

In recent days, Alibaba’s Qwen AI platform has been rolled out into real-world applications, including natural-language flight booking with China Eastern Airlines and on-chain access via 0G Foundation, while the company also entered talks to invest in Chinese AI startup DeepSeek. Together, these moves point to Alibaba pushing Qwen beyond a standalone model into an embedded AI layer for transactions, infrastructure, and enterprise adoption across its ecosystem and partners. We’ll now assess...

Why KBR (KBR) Is Drawing Investor Attention Now KBR (KBR) is back on investors’ radar after recent share performance, with the stock flat over the past day but showing declines over the week, month and past 3 months. That weaker run, alongside a value score of 5 and annual revenue of US$7.8b, is prompting closer inspection of how the company’s government and sustainable technology contracts might factor into longer term expectations. See our latest analysis for KBR. At a share price of...

Vulcan Value Partners has publicly exited CoStar Group (NasdaqGS:CSGP), criticizing continued heavy investment in Homes.com. This follows Third Point's earlier exit and adds pressure on CoStar's management over capital allocation choices. CoStar has announced a $1.5b share repurchase program and highlighted a renewed focus on its core commercial real estate operations. For investors watching CoStar Group at a share price of $36.44, this comes after a sharp reset in market value. The stock...

Earlier this month, Viettel Post, a member of Viettel Group, announced a partnership under which it will become FedEx’s National Network Provider in Vietnam from April 26, 2026, handling pickup, delivery, warehousing, and customs support for cross-border shipments. The collaboration is planned to move nearly 2 million shipments a year across more than 26,000 tons of goods, potentially deepening Vietnam’s logistics links with over 220 international markets and reshaping FedEx’s role in this...

Pfizer and Bristol Myers Squibb are partnering with Mark Cuban's Cost Plus Drug Company to offer Eliquis directly to cash-paying patients on CostPlusDrugs.com. The move centers on improving access and price transparency for the oral anticoagulant, one of the most widely used branded blood thinners. This collaboration marks a shift in how a major biopharma alliance is willing to distribute a branded drug to reach cost-sensitive patients. For investors watching Pfizer, NYSE:PFE, this...

If you are wondering whether Liberty Global's current share price lines up with its underlying worth, this breakdown will help you put some numbers around that question. The stock last closed at US$11.90, with returns of 9.2% year to date and 9.4% over the past year, following a 5.3% decline in the last 7 days and a 3.1% slip over the last 30 days. Recent coverage of Liberty Global has focused on its position within the US telecom sector and how its portfolio of assets fits into longer term...

NBT Bancorp (NBTB) opened 2026 with Q1 revenue of US$178.9 million and basic EPS of US$0.98, supported by quarterly net income of US$51.1 million as the bank reported its latest financial results. The company has seen revenue move from US$147.1 million and EPS of roughly US$0.78 in Q1 2025 to US$178.9 million and US$0.98 per share in Q1 2026, while trailing twelve month revenue reached US$696.6 million and EPS came in at about US$3.54. This sets the backdrop for a story focused on earnings...

monday.com (NASDAQ: MNDY) previously announced it would report its first-quarter 2026 results on Monday, May 11, 2026, with a management webcast at 8:30 a.m. Eastern Time, accessible via the company’s investor relations site. This upcoming earnings release has drawn extra attention because analysts currently expect revenue growth alongside an earnings-per-share decline, highlighting a trade-off between expansion and profitability. With earnings due on May 11 and expectations for revenue...

Cencora (NYSE: COR) has agreed to acquire EyeSouth’s retina business, expanding its footprint in specialty retina services. The transaction is expected to be accretive to adjusted earnings per share within a year of closing. The deal signals a deeper push into higher acuity eye care services and related distribution capabilities. Cencora enters this transaction with its shares at $308.19, after a 1-year return of 8.6% and a 3-year return of 89.6%. Over 5 years, the return stands at 169.0%,...

Wondering whether Take-Two Interactive Software at around US$210.75 is a fair deal, expensive, or potentially underappreciated? This article is built to help you frame that question clearly before you decide what to do next. The stock has been relatively steady over the last week with a 0.6% decline, while the 30 day return of 9.2% contrasts with a year to date return of 16.2% and a 1 year return of 6.5%, which may have you weighing recent momentum against longer term returns. Over the last...

Enterprise Financial Services (EFSC) drew fresh attention after Q1 2026 results and a higher common dividend, with earnings slightly above consensus and management emphasizing stable margins, asset quality progress, and continued balance sheet and deposit growth. See our latest analysis for Enterprise Financial Services. The latest Q1 results and dividend increase come as the share price trades at US$58.83, with an 8.3% 1 month share price return and a 17.2% 1 year total shareholder return...

What Tyson Foods stock’s recent move may be telling you Tyson Foods (TSN) has drawn fresh attention after a recent move that left the shares around $64.03, with returns over the past month and past 3 months both in positive territory. See our latest analysis for Tyson Foods. Recent trading has been a bit softer, with a 1-day share price return of negative 1.84% and a 7-day share price return of negative 1.22%. However, the 30-day and year-to-date share price returns of 4.20% and 10.32%,...

Hartford Insurance Group reported Q1 2026 revenue of US$7.2b and basic EPS of US$3.08, with trailing twelve month revenue at US$28.8b and EPS at US$14.44. Over the past year, revenue has moved from US$26.9b to US$28.8b, while EPS has gone from US$10.20 to US$14.44 on a trailing basis. This gives you a clearer view of how the top and bottom lines have tracked together. Margins have shifted higher over the last twelve months, making this earnings release a key reference point for assessing how...

Digital Realty Trust (DLR) has opened 2026 with Q1 revenue of US$1.6b and basic EPS of US$0.49, while trailing twelve month revenue sits at US$6.3b and EPS at US$3.91, setting a clear benchmark for its data center REIT peers this earnings season. Over recent periods the company has seen revenue move from US$1.4b in Q1 2025 to US$1.6b in Q1 2026, with trailing twelve month EPS rising from US$1.74 to US$3.91, giving investors a clean view of how the top line and per share earnings are tracking...

Earnings surprise and cautious guidance put Zeta Global in focus Zeta Global Holdings (ZETA) drew fresh attention after reporting quarterly revenue of US$394.6 million, up 25.4% year on year and 3.7% above analyst expectations, while pairing that beat with relatively cautious full-year guidance. See our latest analysis for Zeta Global Holdings. The share price has been volatile, with a 7.15% 1 month share price return and a 19.4% 3 month share price decline. However, total shareholder return...

Douglas Emmett (DEI) is drawing investor attention after agreeing to acquire the Bedford Collection, a 246,000-square-foot outpatient medical portfolio in Beverly Hills' Golden Triangle, in a US$260 million joint venture transaction. See our latest analysis for Douglas Emmett. The Bedford Collection deal lands at a time when Douglas Emmett’s 1 month share price return of 14.07% contrasts with a 1 year total shareholder return decline of 20.01%, suggesting near term momentum while longer term...

Molina Healthcare (NYSE:MOH) plans to exit the Medicare Advantage Prescription Drug business starting in 2027. The company is reducing its Marketplace exposure as part of a broader reshaping of its product portfolio. Molina is ramping up its Florida CMS Kids contract, which has different profitability dynamics compared with Medicare and Marketplace plans. Molina Healthcare operates as a managed care company with a focus on government sponsored health programs, and these moves shift emphasis...

Wondering if Cisco Systems at US$89.01 is offering fair value right now, or whether the price already reflects most of the opportunity. The stock has posted returns of 3.2% over 7 days, 8.8% over 30 days, 17.1% year to date, 60.6% over 1 year, 104.7% over 3 years, and 101.7% over 5 years, which naturally raises questions about how much of this performance is justified by fundamentals. Recent coverage has focused on Cisco Systems as a large established name in networking and communications...

Event context and recent share move Ryder System (R) shares have drawn attention after a recent price move, with the stock closing at $253.34. That level comes alongside strong trailing returns over the past year and over the past 3 months. See our latest analysis for Ryder System. The latest move builds on strong momentum, with a 24.41% 1 month share price return contributing to a 30.47% year to date gain and a 1 year total shareholder return of 88.32%. If Ryder System’s run has you thinking...

DoorDash has integrated stablecoin-based payouts via the Tempo blockchain for Dashers and merchants across more than 40 countries. The move introduces a new digital payment rail aimed at faster, lower-cost cross-border settlements for gig workers and partners. This marks one of the earliest large scale stablecoin payment deployments by a major gig economy platform. For investors watching NasdaqGS:DASH, this payment shift comes with the share price at $176.78 and a 3-year return of 188.9%...